Header cover image

U.K. (FTSE) Biotech Industry Analysis

UpdatedMar 18, 2024
DataAggregated Company Financials
Companies28
  • 7D-1.9%
  • 3M-9.1%
  • 1Y-29.4%
  • YTDn/a

Over the last 7 days, the Biotech industry has dropped 1.9%, driven by a pullback from Oxford Biomedica of 9.9%. On the other hand Arecor Therapeutics is actually up 11%. However, the industry is down 29% over the past year. Earnings are forecast to grow by 19% annually.

Industry Valuation and Performance

Has the U.K. Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 18 Mar 2024UK£3.1bUK£897.7m-UK£203,570,600.7534.3x-15x3.4x
Wed, 14 Feb 2024UK£3.3bUK£913.5m-UK£198,137,488.4531.1x-16.7x3.6x
Fri, 12 Jan 2024UK£6.3bUK£1.3b-UK£245,062,810.0036.6x-25.6x4.9x
Sun, 10 Dec 2023UK£6.2bUK£1.3b-UK£245,939,365.0036.9x-25.1x4.9x
Tue, 07 Nov 2023UK£6.4bUK£1.3b-UK£242,901,044.0039.1x-26.4x5x
Thu, 05 Oct 2023UK£6.5bUK£1.3b-UK£251,253,107.0037x-25.8x5.1x
Sat, 02 Sep 2023UK£6.7bUK£1.3b-UK£205,895,302.0023.6x-32.4x5.3x
Mon, 31 Jul 2023UK£6.9bUK£1.3b-UK£208,643,030.0023.6x-33.2x5.5x
Wed, 28 Jun 2023UK£6.8bUK£1.3b-UK£205,298,070.0023.9x-33x5.4x
Fri, 26 May 2023UK£6.9bUK£1.3b-UK£207,220,434.0023.2x-33.5x5.5x
Sun, 23 Apr 2023UK£7.2bUK£1.2b-UK£156,309,305.0023.5x-46x5.8x
Tue, 21 Mar 2023UK£7.2bUK£1.2b-UK£157,701,448.0025.1x-45.4x5.8x
Thu, 16 Feb 2023UK£7.4bUK£1.2b-UK£149,981,915.0028.5x-49.6x6.4x
Sat, 14 Jan 2023UK£7.7bUK£1.2b-UK£140,802,051.0028.5x-54.6x6.6x
Mon, 12 Dec 2022UK£7.5bUK£1.2b-UK£136,794,667.0025x-54.6x6.4x
Wed, 09 Nov 2022UK£7.4bUK£1.2b-UK£142,584,065.0022.4x-51.7x6.3x
Fri, 07 Oct 2022UK£7.4bUK£1.2b-UK£149,502,119.0026.4x-49.6x6.4x
Sun, 04 Sep 2022UK£7.0bUK£1.1b-UK£146,610,750.0034.3x-48x6.3x
Tue, 02 Aug 2022UK£7.3bUK£1.1b-UK£199,533,687.0038.1x-36.8x6.6x
Thu, 30 Jun 2022UK£6.8bUK£1.1b-UK£167,521,479.0035.3x-40.6x6.1x
Sat, 28 May 2022UK£7.2bUK£1.1b-UK£146,482,002.0038.9x-49.1x6.5x
Mon, 25 Apr 2022UK£7.2bUK£1.1b-UK£91,620,330.0037.9x-78.9x6.6x
Wed, 23 Mar 2022UK£7.4bUK£1.1b-UK£98,687,029.0033x-75.1x6.8x
Fri, 18 Feb 2022UK£8.5bUK£1.1b-UK£119,732,737.0035.3x-70.7x7.8x
Sun, 16 Jan 2022UK£9.7bUK£1.1b-UK£123,388,341.0047.3x-78.3x8.9x
Tue, 14 Dec 2021UK£11.1bUK£1.1b-UK£121,180,343.0054x-91.8x10.2x
Thu, 11 Nov 2021UK£11.9bUK£1.1b-UK£149,832,471.0069.8x-79.2x10.9x
Sat, 09 Oct 2021UK£11.8bUK£1.1b-UK£148,479,118.0068.8x-79.5x10.7x
Mon, 06 Sep 2021UK£12.9bUK£1.1b-UK£143,503,184.6256.7x-90x12.3x
Wed, 04 Aug 2021UK£12.1bUK£1.0b-UK£172,541,949.9129.6x-70x11.8x
Sat, 08 May 2021UK£11.5bUK£1.0b-UK£166,311,048.5230.3x-69.3x11.4x
Price to Earnings Ratio

-65x


Total Market Cap: UK£10.8bTotal Earnings: -UK£166,311,048.52Total Revenue: UK£1.0bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Biotech Industry Price to Earnings3Y Average -55.4x202220232024
Current Industry PE
  • Investors are pessimistic on the British Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 7.8x is higher than the industry's current PS ratio of 3.4x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
  • Revenues have also declined 4.0% per year.
  • This means overall sales from these companies are declining and losses are subsequently expanding as well.

Industry Comparison

How does U.K. Biotech compare with similar industries?

GB Market0.65%
Healthcare-1.46%
Biotech-1.90%
Biotech-1.90%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AREC Arecor TherapeuticsUK£1.4811.3%
+UK£4.6m
-43.3%PS13.4x
4BB 4basebioUK£9.753.2%
+UK£3.8m
43.4%PS352.7x
FARN Faron Pharmaceuticals OyUK£1.403.7%
+UK£3.4m
-55.6%PE-3.6x
TRX Tissue Regenix GroupUK£0.692.9%
+UK£1.3m
13.2%PS2.3x
PRTC PureTech HealthUK£1.970.2%
+UK£1.1m
-3.2%PS57.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

FARN

UK£1.40

Faron Pharmaceuticals Oy

7D

3.7%

1Y

-55.6%

OXB

UK£1.89

Oxford Biomedica

7D

-9.9%

1Y

-57.5%

SBTX

UK£0.081

SkinBioTherapeutics

7D

4.5%

1Y

-53.7%

AVCT

UK£0.52

Avacta Group

7D

-8.0%

1Y

-56.5%

ONC

UK£0.17

Oncimmune Holdings

7D

-13.8%

1Y

-53.6%

TRX

UK£0.69

Tissue Regenix Group

7D

2.9%

1Y

13.2%

VRCI

UK£0.098

Verici Dx

7D

-4.9%

1Y

105.3%

ETX

UK£0.12

e-therapeutics

7D

-2.6%

1Y

-10.5%

4BB

UK£9.75

4basebio

7D

3.2%

1Y

43.4%

BVXP

UK£46.00

Bioventix

7D

-3.2%

1Y

24.3%

PRTC

UK£1.97

PureTech Health

7D

0.2%

1Y

-3.2%

OPTI

UK£0.26

OptiBiotix Health

7D

2.0%

1Y

126.7%

NIOX

UK£0.66

NIOX Group

7D

-1.8%

1Y

43.0%